Patent Settlements May Break EU Law
UK’s Paroxetine Referral Raises Competition Issues
Patent-litigation settlements reached almost 20 years ago in the UK over GSK’s Seroxat paroxetine antidepressant may contravene EU competition law, an advocate general has advised the CJEU.
